JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BUTLER, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BUTLER, T. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 113, Issue 2, 178-185, 1955
Copyright © 1955 by American Society for Pharmacology and Experimental Therapeutics


METABOLIC DEMETHYLATION OF 3,5-DIMETHYL-5-ETHYL 2,4-OXAZOLIDINEDIONE (PARAMETHADIONE, PARADIONE)

THOMAS C. BUTLER 1

1 Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

The metabolic conversion of paramethadione to 5-ethyl-5-methyl-2, 4-oxazolidinedione ("EMO") has been studied in the dog and in man.

An analytical method for the determination of EMO in plasma is described.

The resolution of EMO is described.

EMO has been isolated from the urine of dogs after administration of paramethadione as well as of EMO itself. There is a slight preponderance of the levorotatory isomer.

After a single dose of paramethadione to a dog EMO appears in the plasma, increases in concentration for 1 to 2 days, and thereafter slowly disappears. Comparison of the concentrations of EMO attained when paramethadione and when EMO itself are administered indicates that the dog demethylates paramethadione to a large extent.

Chronic oral administration of paramethadione to man results in progressive accumulation of EMO in the plasma. Calculations derived from plasma concentrations of EMO indicate that man converts paramethadione almost completely to EMO.

The therapeutic role of EMO in the clinical use of paramethadione is discussed.

Submitted on September 27, 1954







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1955 by the American Society for Pharmacology and Experimental Therapeutics.